Airain Ltd’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$5.96M Buy
+36,927
New +$6M 0.26% 115
2017
Q1
Sell
-8,840
Closed -$1.04M 890
2016
Q4
$1.04M Sell
8,840
-21,005
-70% -$2.4M 0.08% 232
2016
Q3
$3.36M Sell
29,845
-47,460
-61% -$5M 0.2% 136
2016
Q2
$7.18M Buy
+77,305
New +$6.64M 0.42% 68
2015
Q4
Sell
-4,007
Closed -$298K 932
2015
Q3
$298K Sell
4,007
-38,607
-91% -$2.77M 0.02% 610
2015
Q2
$2.73M Buy
+42,614
New +$2.95M 0.15% 169

Other funds holding IDXX

Airain Ltd's IDXX Position: Q2 2017 in Review

Airain Ltd opened a new position in Idexx Laboratories (IDXX) in Q2 2017: 36,927 shares worth $5.96M. The stake represents 0.26% of the portfolio and ranks #115 among its holdings. This is a return to the name: Airain Ltd previously reported a position in IDXX as recently as Q4 2016.

Airain Ltd first reported a position in IDXX in Q2 2015 and has held it in 6 quarters since. The position peaked at $7.18M in Q2 2016. 582 funds tracked by Wall St. Rank hold IDXX as of Q2 2017.

  • Airain Ltd held 36,927 shares of Idexx Laboratories worth $5.96M as of Q2 2017.
  • Idexx Laboratories was a new Airain Ltd position in Q2 2017.
  • Idexx Laboratories made up 0.26% of Airain Ltd's portfolio in Q2 2017, its #115 holding.
  • Airain Ltd first reported a position in Idexx Laboratories in Q2 2015 and has held it in 6 quarters since.
  • Airain Ltd's Idexx Laboratories position peaked at $7.18M in Q2 2016.
  • 582 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2017.

Based on Airain Ltd's 13F filing for Q2 2017, filed 8 Aug 2017.